Cargando…
Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant–palonosetron combination
PURPOSE: The purpose of this review is to summarize and discuss the recently published data (both original studies and reviews) on the oral medication NEPA, consisting of netupitant (a neurokinin-1 receptor antagonist [NK1RA], 300 mg dose) and palonosetron (5-hydroxytryptamine [serotonin or 5HT] typ...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859423/ https://www.ncbi.nlm.nih.gov/pubmed/27194913 http://dx.doi.org/10.2147/TCRM.S81126 |